|
0
|
|
Prevalence and factors associated with tuberculosis recurrence among key vulnerable populations in the Ashanti region, Ghana.
(link.springer.com)
|
Adangabe E
…
Mohammed A
BMC Infectious Diseases
2026-08-18
|
#tb
#epidemiology
#recurrence
#vulnerable populations
#infection
|
|
0
|
|
Repurposing Penfluridol to combat mycobacteria via bioenergetic collapse.
(journals.asm.org)
|
Li Y
…
Dong N
Microbiology Spectrum
2026-08-18
|
#amr
#tb
#repurposing
#bioenergetics
|
|
0
|
|
Congenital tuberculosis presenting as acute cervical lymphadenitis in a 28-week preterm infant.
(linkinghub.elsevier.com)
|
Ge M
…
Jiang S
Lancet Infectious Diseases
2026-08-18
|
#tb
#neonatal
#congenital
#infection
#lymphadenitis
|
|
0
|
|
Adaptation of the molecular bacterial load assay for real-time quantification of Mycobacterium tuberculosis in the clinical routine laboratory.
(journals.asm.org)
|
Andersson B
…
Schon T
Microbiology Spectrum
2026-08-18
|
#tb
#quantification
#diagnostics
#molecular
#rna
|
|
0
|
|
Antimicrobial peptides for tuberculosis in a post-antibiotic era: from in vitro promise to therapeutic potential.
(nature.com)
|
Dominic G
…
Oyama LB
npj Antimicrobials and Resistance
2026-08-18
|
#antimicrobial peptides
#tb
#drug resistance
#therapeutics
#mycobacterial
|
|
0
|
|
Comparison of VPM1002 with BCG in the prevention of tuberculosis in newborn infants: a multicentre, double-blind, randomised, phase 3, non-inferiority trial.
(linkinghub.elsevier.com)
|
Nduba V
…
Shaligram U
Lancet Infectious Diseases
2026-08-18
|
#vaccination
#tb
#clinical trial
#immunogenicity
|
|
0
|
|
The bacterial pH gradient contributes to persistence in Mycobacterium tuberculosis.
(journals.asm.org)
|
Eldesouky HE
…
Sherman DR
mBio
2026-08-18
|
#tb
#persistence
#antibiotic tolerance
#transcriptomics
#amr
|